Cytomegalovirus reactivation after CD19 CAR T-cell therapy is clinically significant
George Chen, Megan M. Herr, Jan Nowak, Christine M. Ho, Nikolaos G. Almyroudis, Kristopher Attwood, John P. Bonnewell, Marissa Walsh, Brahm H. Segal, Maureen Ross, Philip L. McCarthy, Theresa Hahn
Abstract
Not available.
Topics & Concepts
CytomegalovirusVirologyMedicineCD19CAR T-cell therapyImmunologyHerpesviridaeViral diseaseVirusT cellAntibodyChimeric antigen receptorImmune systemCAR-T cell therapy researchVirus-based gene therapy researchNanowire Synthesis and Applications